Today’s top gainers include the company CR Bard Inc. (NYSE:BCR) which is in the industry Medical Instruments & Supplies, gaining -0.27% today. In the last week its performance is 0.76%, and 1.78% for the past quarter. Currently, CR Bard Inc., BCR has a target price of 243.83, so today’s gain of -0.27% is a significant step towards its target price. The GAP today is therefore -0.39%.
CR Bard Inc. (NYSE:BCR), has a market cap of 16478.9, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 92.00%.
At the current price of 222.5, it has a dividend yield of 0.47%, and its target price is 243.83. This is with a profit margin of 9.10%, and total debt/equity of 1.01. CR Bard Inc. (NYSE:BCR) has a P/E of 44.07, as well as a forward P/E of 19.75.
With a current EPS of 5.06, and a forecasted EPS growth for next year at 11.12%,CR Bard Inc. (NYSE:BCR) has had a EPS growth for the past five years at -19.80%. For the next five years EPS growth is projected to be 10.87%.
Performance for the year is 13.28%. Since its IPO date on 4/6/1983, the total performance to date is 18.20%.
Volume today for CR Bard Inc. (NYSE:BCR), is 308653, while its average volume is 476.46. Whilst the total gain today was -0.27%, it did have a day high of -6.97%.
Volatility for this week has been at 0.96%, and 1.28% for the month. The 52-week low for CR Bard Inc., BCR has been 29.67%, while the 52-week-high has reached -6.97%.
Looking at its return of investments, which is 6.40%, and its return on assets is 6.30%. CR Bard Inc. (NYSE:BCR) has an operating margin of 14.10%. With a sales growth of -63.30% quarter over quarter. Bearing in mind that CR Bard Inc., BCR is in the sector Healthcare, its long-term debt/equity is 1.01, and has a current ratio of 2.4 and 1.9 for quick ratio.
So what is the value of CR Bard Inc.? Well its PEG is 4.05, and the P/S is 4.65, along with a P/B of 10.14. Meanwhile it has a p/cash of 20.66.